Cargando…

Flavones provide resistance to DUX4-induced toxicity via an mTor-independent mechanism

Mostrar otras versiones (1)

Facioscapulohumeral muscular dystrophy (FSHD) is among the most common of the muscular dystrophies, affecting nearly 1 in 8000 individuals, and is a cause of profound disability. Genetically, FSHD is linked to the contraction and/or epigenetic de-repression of the D4Z4 repeat array on chromosome 4,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Justin, Huang, Shushu, Koczwara, Katherine, Ho, Vincent, Woodman, Keryn, Lek, Angela, Arbiser, Jack, Lek, Monkol, DeSimone, Alec
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915774/ https://www.ncbi.nlm.nih.gov/pubmed/36778471 http://dx.doi.org/10.21203/rs.3.rs-2452222/v1

Ejemplares similares

Flavones provide resistance to DUX4-induced toxicity via an mTor-independent mechanism
por: Cohen, Justin, et al.
Publicado: (2023)

Cellular and animal models for facioscapulohumeral muscular dystrophy
por: DeSimone, Alec M., et al.
Publicado: (2020)

Development of Assays to Measure GNE Gene Potency and Gene Replacement in Skeletal Muscle
por: Zygmunt, Deborah A., et al.
Publicado: (2023)

Decoding the genetics of rare disease: an interview with Monkol Lek
por: Lek, Monkol
Publicado: (2022)

Phylogenetic analysis of ferlin genes reveals ancient eukaryotic origins
por: Lek, Angela, et al.
Publicado: (2010)

Envisioning the next human genome reference
por: Lek, Monkol, et al.
Publicado: (2021)

Gene discovery informatics toolkit defines candidate genes for unexplained infertility and prenatal or infantile mortality
por: Dawes, Ruebena, et al.
Publicado: (2019)

Genetic variance in human disease – modelling the future of genomic medicine
por: Lek, Monkol, et al.
Publicado: (2022)

Editorial: Application of Omics Approaches to the Diagnosis of Genetic Neurological Disorders
por: Legati, Andrea, et al.
Publicado: (2021)

Telomeres cooperate in zygotic genome activation by affecting DUX4/Dux transcription
por: Zhang, Xiaorui, et al.
Publicado: (2023)

All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells
por: Gamper, Christopher J., et al.
Publicado: (2012)

Quantifying unobserved protein-coding variants in human populations provides a roadmap for large-scale sequencing projects
por: Zou, James, et al.
Publicado: (2016)

Whole-exome sequencing identifies mutations in MYMK in a mild form of Carey-Fineman-Ziter syndrome
por: Alrohaif, Hadil, et al.
Publicado: (2018)

DUX Hunting—Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia
por: Rehn, Jacqueline A., et al.
Publicado: (2020)

Activity-independent targeting of mTOR to lysosomes in primary osteoclasts
por: Wang, Andrew, et al.
Publicado: (2017)

High-throughput screening identifies inhibitors of DUX4-induced myoblast toxicity
por: Bosnakovski, Darko, et al.
Publicado: (2014)

Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4
por: Eidahl, Jocelyn O., et al.
Publicado: (2016)

The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner
por: Zhang, Ying, et al.
Publicado: (2021)

Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease
por: Hangul, Ceren, et al.
Publicado: (2022)

Mechanical Stimulation Induces mTOR Signaling via an ERK-Independent Mechanism: Implications for a Direct Activation of mTOR by Phosphatidic Acid
por: You, Jae Sung, et al.
Publicado: (2012)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Flavones and Flavone Glycosides from Salvia macrosiphon Boiss
por: Gohari, Ahmad Reza, et al.
Publicado: (2011)

Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation
por: Ansseau, Eugénie, et al.
Publicado: (2016)

Conserved roles for murine DUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons
por: Hendrickson, Peter G., et al.
Publicado: (2017)

DUX4(HD2)-DNA(ERG) structure reveals new insight into DUX4-Responsive-Element
por: Dong, Xue, et al.
Publicado: (2018)

Human DUX4 and mouse Dux interact with STAT1 and broadly inhibit interferon-stimulated gene induction
por: Spens, Amy E, et al.
Publicado: (2023)

p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy
por: Bosnakovski, Darko, et al.
Publicado: (2017)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

An evaluation tool for FKBP12-dependent and -independent mTOR inhibitors using a combination of FKBP-mTOR fusion protein, DSC and NMR
por: Sekiguchi, Mitsuhiro, et al.
Publicado: (2011)

RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy
por: Mariot, Virginie, et al.
Publicado: (2021)

Antagonism among DUX family members evolved from an ancestral toxic single homeodomain protein
por: Bosnakovski, Darko, et al.
Publicado: (2023)

Antagonism among DUX family members evolved from an ancestral toxic single homeodomain protein
por: Bosnakovski, Darko, et al.
Publicado: (2023)

Rapamycin directly activates lysosomal mucolipin TRP channels independent of mTOR
por: Zhang, Xiaoli, et al.
Publicado: (2019)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

mTOR Modulates Methamphetamine-Induced Toxicity through Cell Clearing Systems
por: Lazzeri, Gloria, et al.
Publicado: (2018)

CIC-DUX4 Sarcoma Involving the Skull Base: A Rare Presentation and Review of the Literature
por: Hobday, Sara B., et al.
Publicado: (2023)

A family history of DUX4: phylogenetic analysis of DUXA, B, C and Duxbl reveals the ancestral DUX gene
por: Leidenroth, Andreas, et al.
Publicado: (2010)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pf2flus5mogtodtom1io3mhqnb